This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Atresia of the aorta Atresia of the Aorta


1. History

Atresia of the aorta is one of the most severe forms of congenital heart malformation and has been rarely reported in autopsy findings since the early 20th century. Before the introduction of cardiopulmonary bypass in the 1950s, most patients died in the neonatal period, and surviving cases were extremely limited. In the 1970s, as Norwood and others systematized staged palliative surgery for lesions related to hypoplastic left heart syndrome (HLHS), surgical treatment of left heart obstructive lesions including aortic atresia began in earnest. After the Norwood procedure was first reported in 1983, a three-stage palliative surgical system consisting of the Norwood procedure followed by the Glen shunt and the Fontan operation was established. In the 2000s, the hybrid approach (main pulmonary artery banding + ductal stent) was developed and is used as an alternative to stage 1 Norwood surgery in high-risk neonates. Today, heart transplantation has become the final treatment option, and bridging therapy using mechanical ventricular assist devices (VADs) is also applied clinically.

In Korea, the Norwood procedure was introduced in the 1990s, mainly at specialized pediatric cardiac surgery centers, and surgical outcomes have improved greatly since the 2000s. Registration under the rare disease Special Copayment Reduction (V272) is possible, and the annual number of diagnoses is very small, placing it in the rare disease category.

2. Causes

Aortic atresia more often occurs as part of hypoplastic left heart syndrome (HLHS) than as an isolated lesion. Embryologically, reduced blood flow to the left heart during fetal life impairs the development of normal cardiovascular structures. Restricted flow through the foramen ovale or a ventricular septal defect, mitral valve abnormalities, and similar conditions are known to reduce left ventricular filling, leading to failure of aortic development.

Aortic valve atresia is a condition in which the valve structure at the atrioventricular junction or the ventriculoarterial junction is completely closed. In this case, the left ventricle becomes severely hypoplastic or nearly absent, and the systemic circulation depends entirely on right-to-left shunting through the ductus arteriosus. Coronary blood flow is also supplied in the reverse (retrograde) direction.

Isolated aortic atresia is extremely rare and is mostly found in the context of complex congenital heart malformations. Reported genetic predispositions include chromosomal abnormalities (particularly Turner syndrome, 45,X) and some single-gene variants (NKX2.5, GATA4, etc.). Environmental factors such as maternal diabetes, phenylketonuria, and retinoid exposure are also known risk factors.

3. Genetics

Left-sided obstructive lesions, including aortic atresia, are strongly associated with certain chromosomal abnormalities. Turner syndrome (45,X) has a markedly high incidence of aortic abnormalities (coarctation of the aorta, bicuspid aortic valve, aortic atresia, etc.) and is also associated with HLHS. Left-sided obstructive lesions are also observed at high frequency in the 11q11 microdeletion (Jacobsen syndrome).

Among single-gene variants, variants in cardiac development transcription factor genes such as NKX2.5, GATA4, and TBX5 are known causes of complex congenital heart malformations, but a specific association between these genes and aortic atresia alone has not yet been sufficiently established. There are also reports that GJA1 (Connexin 43) gene variants are associated with some left-sided obstructive lesions.

In studies of familial cases, left-sided obstructive lesions tend to show familial clustering, and the sibling recurrence risk is known to be higher than in the general population (about 2–4%). This should be taken into account in genetic counseling, and active use of prenatal ultrasound and fetal echocardiography is recommended.

4. General epidemiology

Aortic atresia is a very rare lesion even among congenital heart malformations, reported at about 1–3 per 100,000 births. Compared with the overall incidence of HLHS of about 16–36 per 100,000 births, pure aortic atresia (complete atresia of the aortic valve or the aorta itself) accounts for a portion of these.

Some reports indicate a slightly higher frequency in boys, but a statistically significant difference has not been consistently shown. Large-scale data on racial differences are lacking.

According to Health Insurance Review & Assessment Service (HIRA) data in Korea, the number of patients registered under code Q25.2 is very small, at several dozen per year. Registration under Special Copayment Reduction V272 provides medical cost relief. Most patients are diagnosed in the neonatal period and referred to specialized pediatric cardiac centers, and cases surviving to adulthood are limited to those who have undergone staged palliative surgery or heart transplantation.

With the spread of fetal ultrasound screening, the prenatal diagnosis rate is increasing, and when diagnosed prenatally, preparation of a multidisciplinary team before delivery and immediate intervention after delivery are important for improving prognosis.

5. Pathophysiology

In aortic atresia, the left ventricle is extremely hypoplastic or functionally absent, and the aortic valve is completely atretic. As a result, the systemic circulation depends on retrograde systemic circulation supplied in reverse from the pulmonary artery through the ductus arteriosus (DA) (ductal-dependent systemic circulation).

Coronary blood flow is also supplied retrogradely. Blood flows in the order right ventricle → pulmonary artery → ductus arteriosus → aorta → coronary arteries. In this state, intra-aortic pressure and coronary perfusion pressure depend heavily on ductal patency, so spontaneous closure of the ductus arteriosus results in immediate shock and death.

The pulmonary and systemic circulations are connected by a shunt at the atrial level (atrial septal defect or foramen ovale). If the atrial-level shunt is restrictive, pulmonary congestion intensifies and hypoxemia worsens. Therefore, administering prostaglandin E1 (PGE1) immediately after birth to maintain ductal patency is essential for survival.

Because a single ventricle (the right ventricle) handles both the systemic and pulmonary circulations, ventricular workload increases over the long term, with a tendency to progress to heart failure. Even after the Fontan operation, long-term complications (protein-losing enteropathy, Fontan-associated heart failure, etc.) may occur due to the structural limitations of single-ventricle circulation.

6. Symptoms

Patients with aortic atresia often develop symptoms immediately after birth. While the ductus arteriosus remains patent, they may appear temporarily stable, but they deteriorate rapidly once the ductus begins to close.

Main early symptoms:

Worsening of symptoms with ductal closure:

This worsening of symptoms can be difficult to distinguish from cardiogenic shock, and differentiation from neonatal sepsis is necessary.

7. Signs

On physical examination, patients with aortic atresia show the following characteristic signs:

Electrocardiogram: right heart hypertrophy findings are typical. P-wave changes, right axis deviation, and a right ventricular hypertrophy pattern in V1 are seen.

Chest X-ray: cardiomegaly and increased pulmonary vascular markings or pulmonary congestion. The cardiac silhouette may appear egg-shaped.

Echocardiography: confirms aortic valve atresia, extreme left ventricular hypoplasia, retrograde aortic arch flow, and ductal patency. Confirming the coronary artery origins is also important.

8. Screening

The following screening methods are used for early detection of aortic atresia:

Prenatal ultrasound: the first step is identifying abnormal findings on the four-chamber view in a detailed ultrasound at 18–22 weeks of gestation. Fetal echocardiography is performed when findings such as left ventricular hypoplasia, aortic hypoplasia, or non-visualization of the aortic valve are suspected. When diagnosed prenatally, a delivery plan is established through a multidisciplinary team meeting before delivery, and delivery at a tertiary medical institution with pediatric cardiac surgery is recommended.

Pulse Oximetry Screening: as a newborn screening test, SpO₂ is measured on the right hand (preductal) and a foot (postductal) within 24–48 hours after birth. If SpO₂ at both sites or either site is below 95%, or the difference between the two sites is 3% or more, the result is judged positive and echocardiography is performed.

Neonatal echocardiography: if screening findings are abnormal, echocardiography is performed immediately to confirm the anatomical diagnosis.

Genetic testing: if associated malformations are present or a chromosomal abnormality is suspected, karyotype analysis and chromosomal microarray testing are performed.

9. Diagnosis

The following tests are used to confirm aortic atresia and for preoperative anatomical assessment:

Echocardiography: the primary diagnostic tool. Evaluates whether the aortic valve is atretic, left ventricular size and function, mitral valve morphology, aortic size, atrial septal defect size, and the presence of the ductus arteriosus and the direction of flow. Abnormal coronary artery origins (sinusoidal connections) are also checked.

Cardiovascular CT angiography (CTA): evaluates aortic arch anatomy, coronary artery origins and course, pulmonary venous connections, etc. in three dimensions. It is essential for preoperative anatomical mapping.

Cardiac MRI: useful for evaluating ventricular volume, myocardial function, and blood flow. However, it has the limitation of requiring sedation in neonates.

Cardiac Catheterization: allows hemodynamic assessment (pulmonary vascular resistance, ventricular function) and interventional procedures (atrial septal enlargement) to be performed simultaneously. If there is a restrictive atrial septal defect, emergency balloon atrial septostomy (Rashkind procedure) is performed to relieve pulmonary congestion.

Blood tests: arterial blood gas analysis, lactate, electrolytes, and renal function tests assess the overall condition. Genetic testing is also performed at the same time.

10. Treatment

Treatment of aortic atresia is complex and requires a multistage approach.

Medical stabilization:

Staged Palliation:

Heart transplantation: performed when staged palliative surgery is not possible or has failed, or when single-ventricle function declines over the long term. The shortage of donor organs for pediatric heart transplantation is a major problem.

Hybrid approach: in high-risk neonates, instead of stage 1 Norwood, initial stabilization is achieved with pulmonary artery banding + ductal stent placement, followed by a comprehensive stage 2 operation.

11. Prognosis

Surgical outcomes for HLHS, including aortic atresia, have steadily improved, but it remains one of the congenital heart malformations with the poorest prognosis.

Surgical mortality: mortality of stage 1 Norwood surgery has fallen to 10–20% at specialized centers, but remains high at low-risk institutions. The period between stages (interstage mortality) is an important issue, and inpatient monitoring programs have been introduced.

Long-term prognosis (after the Fontan operation):

After heart transplantation, 5-year survival is reported to exceed 70%, but long-term rejection and graft-related complications remain ongoing challenges.

12. Prevention

Aortic atresia is a structural congenital heart malformation, and no established primary prevention exists to date. However, the following approaches help reduce risk and enable early detection:

Prenatal care:

Genetic counseling:

Folic acid intake: some studies suggest that folic acid intake before and in early pregnancy may lower the risk of some congenital heart malformations, but a specific effect on aortic atresia has not been established.

Newborn screening: early detection of congenital heart malformations by pulse oximetry after birth enables diagnosis before ductal closure, preventing emergencies.

13. References

  1. Ohye RG, et al. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010;362(21):1980-1992. PMID:20505177
  2. Feinstein JA, et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol. 2012;59(1 Suppl):S1-42. PMID:22192721
  3. Rychik J, et al. Characterization of the great arteries in hypoplastic left heart syndrome. Ann Thorac Surg. 1999;67(4):1097-1103. PMID:10320254
  4. Tweddell JS, et al. Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg. 2009;88(4):1291-1299. PMID:19766826
  5. Diab KA, et al. Outcomes of single-ventricle palliation in patients with hypoplastic left heart syndrome and intact/highly restrictive atrial septum. Pediatr Cardiol. 2015;36(8):1711-1716. PMID:26215476
  6. Khairy P, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2017;136(19):1813-1825. PMID:29018170
  7. Warnes CA, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease. J Am Coll Cardiol. 2008;52(23):e143-263. PMID:19038677
  8. Reller MD, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807-813. PMID:18657826
  9. Pizarro C, et al. Right ventricle to pulmonary artery conduit improves outcome after stage I Norwood for hypoplastic left heart syndrome. Circulation. 2003;108(Suppl 1):II155-160. PMID:12970225
  10. Stasik CN, et al. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg. 2006;131(2):412-417. PMID:16434271